In this issue:
Use of PET/MRI to detect malignant transformation in patients with NF1
Effects of selumetinib on plexiform neurofibromas in patients with NF1
Effects of selumetinib on inoperable plexiform neurofibromas
Long-term use of selumetinib for plexiform neurofibromas in children
Efficacy and safety of selumetinib:a meta-analysis
Safety and pharmacokinetics of selumetinib in Chinese patients
Trametinib in the treatment of low-grade gliomas in children with NF1
Axitinib in patients with NF2-related schwannomatosis and vestibular schwannomas
Bevacizumab in patients with NF2-related schwannomatosis
Assessment of bone health in patients with NF1
Cardiac complications in children with NF1
Social cognition in children with NF1
Perspectives of adolescents with cutaneous neurofibromas
Expert contributor
Professor Nick Freezer is a Paediatric Respiratory Physician and the Medical Director of the Monash Children’s Hospital, Melbourne at Monash Health. He is also a Professor of Paediatrics at Monash University, and until recently the Leader of the Children’s Health research theme of Monash Partners Academic Health Science Centre and Monash Health Translation Precinct. A […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.